Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: busulfan
Drug: melphalan
Drug: fludarabine
Biological: anti-thymocyte globulin (ATG)
Procedure: a T cell depleted stem cell transplant

First Posted Date: 2013-01-01

Last Posted Date: 2025-01-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT01758328

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis

Not Applicable

Completed

Conditions: Metastatic or Recurrent Lesions in the Spine
Metastatic or Recurrent Lesions in the Pelvis

Interventions: Radiation: Ir-192 high dose rate (HDR)

First Posted Date: 2012-12-31

Last Posted Date: 2018-03-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT01757717

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Phase 1

Active, not recruiting

Conditions: Neuroblastoma

Interventions: Biological: Hu3F8 With GM-CSF

First Posted Date: 2012-12-31

Last Posted Date: 2025-01-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 186

Registration Number: NCT01757626

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma
Non-Hodgkin's Lymphoma

Interventions: Drug: Romidepsin
Drug: Lenalidomide

First Posted Date: 2012-12-24

Last Posted Date: 2024-11-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 49

Registration Number: NCT01755975

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Saint Francis/Mount Sinai Regional Cancer Center, Hartford, Connecticut, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

and more 4 locations

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Abiraterone acetate plus degarelix
Drug: Abiraterone acetate
Drug: Degarelix

First Posted Date: 2012-12-18

Last Posted Date: 2021-11-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 124

Registration Number: NCT01751451

Locations: 🇺🇸
Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States
🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸
NorthShore University Health System, Long Island City, New York, United States

and more 13 locations

A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections

Not Applicable

Completed

Conditions: Liver Cancer

Interventions: Other: Perihepatic Phlebotomy

First Posted Date: 2012-12-13

Last Posted Date: 2019-12-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 117

Registration Number: NCT01749332

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma
Non-Hodgkin's Lymphoma
Leukemia
Myelodysplastic Syndrome

Interventions: Biological: Palifermin
Biological: Lupron
Procedure: peripheral blood stem cell transplantation
Radiation: Total-Body Irradiation (TBI)
Drug: Thiotepa
Drug: Cyclophosphamide
Drug: Degarelix

First Posted Date: 2012-12-11

Last Posted Date: 2025-01-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 82

Registration Number: NCT01746849

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Pomalidomide
Procedure: stem cell
Drug: Dexamethasone
Drug: Clarithromycin

First Posted Date: 2012-12-10

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 23

Registration Number: NCT01745588

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
North Shore LIJ, New Hyde Park, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 6 locations

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Recruiting

Conditions: Cancer Patients

Interventions: Behavioral: The Integrated Cancer Care Access Network (ICCAN)
Behavioral: Usual and Customary Group (U&C)

First Posted Date: 2012-12-05

Last Posted Date: 2024-07-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 334

Registration Number: NCT01742143

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Lincoln Hospital and Mental Health Center, Bronx, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States

and more 8 locations

Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health

Not Applicable

Completed

Conditions: Breast Cancer
Endometrial Cancer

Interventions: Other: HLA vaginal gel (HyaloGYN®),
Behavioral: questionnaires

First Posted Date: 2012-11-30

Last Posted Date: 2021-07-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 106

Registration Number: NCT01738152

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy